A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene

Archives of Neurology

Volumn 60, Issue 10, 2003, Pages 1454-1456

  Soliveri, Paola ^a   Rossi, Giacomina ^b   Monza, Daniela ^a   Tagliavini, Fabrizio ^b   Piacentini, Sylvie ^a   Albanese, Alberto ^a   Bugiani, Orso ^b   Girotti, Floriano ^a  

^a Developmental Neurology Division   (Italy)

^b Division of Neuropathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; TAU PROTEIN;

ADULT; ARTICLE; BALANCE DISORDER; BEHAVIOR DISORDER; BRADYKINESIA; BRAIN ATROPHY; BRAIN FUNCTION; CASE REPORT; CHROMOSOME 17; CODON; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; EXON; FEMALE; FRONTOTEMPORAL DEMENTIA; GAZE PARALYSIS; GENETIC LINKAGE; HUMAN; MENTAL DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN MOTIF; SYMPTOMATOLOGY;

CHROMOSOMES, HUMAN, PAIR 17; CODON; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0141958877     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.10.1454     Document Type: Article

References (18)

1. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1-9.
2. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996;47:1184-1189.
3. Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn. 1995;28:311-320.
4. Hauw JUJU, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015-2019.
5. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm. 1994;42(suppl):137-152.
6. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999;246(suppl 2):6-15.
7. Rojo A, Pernaute RS, Fontan A, et al. Clinical genetics of familial progressive supranuclear palsy. Brain. 1999;122:1233-1245.
8. Arvanitakis Z, Wszolek ZK. Recent advances in understanding of tau protein and movement disorders. Curr Opin Neurol. 2001;14:491-497.
9. Clark LN, Poorkaj P, Wszolek ZK, et al. Pathogenic implications of mutation in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A. 1998;95:13103-13107.
10. Delisle MB, Murrell JR, Richardson R, et al. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a taupathy with dementia and supranuclear palsy. Acta Neuropathol. 1999;98:62-77.
11. Yasuda M, Kawamata T, Komure O, et al. A mutation in the microtubule-associated tau protein in pallido-nigro-luysian degeneration. Neurology. 1999;53:864-868.
12. Arima K, Kowalska A, Hasegawa M, et al. Two brothers with fronto-temporal dementia and parkinsonism with an N279K mutation of the tau gene. Neurology. 2000;54:1787-1795.
13. Grisoli M, Fetoni V, Savoiardo M, Girotti F, Bruzzone MG. MRI in corticobasal degeneration. Eur J Neurol. 1994;2:547-552.
14. Brooks DJ. PET studies in progressive supranuclear palsy. J Neural Transm. 1994;42(suppl):119-134.
15. Stanford PM, Halliday GM, Brooks WS, et al. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutation. Brain. 2000;123:880-893.
16. Wszolek ZK, Kardon RH, Wolters EC, et al. Fronto-temporal dementia and parkinsonism linked to chromosome (17 FTDP-17): PPND family: a longitudinal videotape demonstration. Mov Disord. 2001;16:756-760.
17. Wszolek ZK, Uitti RJ, Hutton M. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration [letter]. Neurology. 2000;54:2028-2030.
18. Tsubol Y, Uitti RJ, Delisle MB, et al. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallido-ponto-nigral degeneration kindred and a French family. Arch Neurol. 2002;59:943-950.